bluebird bio Inc (BLUE)
0.3501
+0.05
(+17.52%)
USD |
NASDAQ |
Nov 22, 16:00
0.34
-0.01
(-2.88%)
After-Hours: 20:00
bluebird bio Revenue (Quarterly): 10.61M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 10.61M |
| June 30, 2024 | 16.10M |
| March 31, 2024 | 18.57M |
| December 31, 2023 | 7.834M |
| September 30, 2023 | 12.39M |
| June 30, 2023 | 6.89M |
| March 31, 2023 | 2.381M |
| December 31, 2022 | 0.063M |
| September 30, 2022 | 0.071M |
| June 30, 2022 | 1.519M |
| March 31, 2022 | 1.945M |
| December 31, 2021 | 1.606M |
| September 30, 2021 | 1.019M |
| June 30, 2021 | 0.143M |
| March 31, 2021 | 0.894M |
| December 31, 2020 | -240.03M |
| September 30, 2020 | 19.27M |
| June 30, 2020 | 198.89M |
| March 31, 2020 | 21.86M |
| December 31, 2019 | -34.68M |
| September 30, 2019 | 8.91M |
| June 30, 2019 | 13.30M |
| March 31, 2019 | 12.47M |
| December 31, 2018 | 19.24M |
| September 30, 2018 | 11.53M |
| Date | Value |
|---|---|
| June 30, 2018 | 7.851M |
| March 31, 2018 | 15.96M |
| December 31, 2017 | 4.168M |
| September 30, 2017 | 7.711M |
| June 30, 2017 | 16.72M |
| March 31, 2017 | 6.832M |
| December 31, 2016 | 1.552M |
| September 30, 2016 | 1.552M |
| June 30, 2016 | 1.552M |
| March 31, 2016 | 1.499M |
| December 31, 2015 | 1.472M |
| September 30, 2015 | 1.324M |
| June 30, 2015 | 4.94M |
| March 31, 2015 | 6.344M |
| December 31, 2014 | 6.386M |
| September 30, 2014 | 6.365M |
| June 30, 2014 | 6.335M |
| March 31, 2014 | 6.335M |
| December 31, 2013 | 6.335M |
| September 30, 2013 | 6.385M |
| June 30, 2013 | 6.334M |
| March 31, 2013 | 1.127M |
| December 31, 2012 | 0.085M |
| September 30, 2012 | 0.085M |
| June 30, 2012 | 0.085M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
-240.03M
Minimum
Dec 2020
198.89M
Maximum
Jun 2020
2.368M
Average
2.163M
Median
Revenue (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 0.035M |
| Perspective Therapeutics Inc | -- |
| Protalix BioTherapeutics Inc | 17.96M |
| Electromed Inc | 14.67M |
| Armata Pharmaceuticals Inc | -- |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -60.81M |
| Total Expenses (Quarterly) | 74.72M |
| EPS Diluted (Quarterly) | -0.31 |
| Enterprise Value | 68.02M |
| Gross Profit Margin (Quarterly) | -11.02% |
| Profit Margin (Quarterly) | -573.0% |
| Earnings Yield | -511.3% |
| Normalized Earnings Yield | -507.15 |